A Study to Investigate FP002 in Subjects With Advanced Malignancies

Clinical trial NCT05982080 · UNKNOWN

Trial details

NCT number: NCT05982080
Sponsor: Guangdong Fapon Biopharma Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-08-02
Primary completion: 2025-04-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.